Study on the efficacy and safety of Orelabrutinib Combined with Rituximab in the Treatment of Ralapaed and refractory warm Autoimmune Hemolytic Anemia (ChiCTR) - Oct 16, 2026 - P=N/A | N=29 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Zhejiang University School of Medicine; The First Affiliated Hospital of Zhejiang University School of Medicine
New trial • Anemia • Autoimmune Hemolytic Anemia • Hematological Disorders • Immunology
|